| Subcutaneous | | |
| Disease | # of Models | Models |
| Bladder Cancer | 4 | RT112; HT-1376; RT112 84; UM-UC-3 |
| Breast Cancer | 14 | MDA-MB-231(x);MDA-MB-468(x2); MDA-MB-436; DU4475; HCC70; MX-1(TNBC total 6);MCF-7(x); ZR-75-1;BT-474(x); T-47D(x); HCC1569; HCC1954; MCF-7-Her2(x); BT-474EEI |
| Cervical Adenocarcinoma | 1 | Hela |
| Colorectal Cancer | 12 | HCT-116; SW620; HT-29; SW480; DLD-1; COLO 205; NCI-H716; RKO; SW948; Colo320DM; LOVO; KM12-Luc |
| Endometrium Adenocarcinoma | 2 | AN3CA; MFE-296 |
| Epidermoid Carcinoma | 2 | A431; CAL-27 |
| Epithelioid Sarcoma | 1 | VA-ES-BJ |
| Esophageal Cancer | 1 | T.T |
| Fibrosarcoma | 1 | HT-1080 |
| Gastric Cancer | 8 | HGC-27(x); MKN-45; AGS; NCI-N87; SNU-16; OCUM-1; SNU-5; MKN-1 |
| Glioblastoma | 7 | U87MG; U87MG (nude Rat); U87MG-EGFR VIII, LN229; U251; AM-38; AM-38-Luc |
| Hypopharyngeal | 1 | FaDu |
| Kidney Cancer | 6 | Caki-1; A-498; 786-O; G-401; ACHN; OS-RC-2 |
| Leukemia | 22 | K562; HL-60; MV-4-11; MOLT-4; Kasumi-1; KU812; THP-1; TF-1; HEL 92.1.7; SKM-1; NOMO-1; ARH-77; Kopn-8; MOLM-13; KG-1; OCI-AML-2 (nude Rat); OCI-AML-3 (nude Rat); OCI-AML-2; OCI-AML-3; RS4;11; EOL-1; SKNO-1 |
| Liver Cancer | 6 | Hep 3B2.1-7; SK-HEP-1; HuH-7; Hep3B-OS8-Hpdl1a2; HepG2; JHH-7 |
| Lung Cancer | 65 | NCI-H446; NCI-H2171; NCI-H841; SHP-77; DMS 53; NCI-H69;NCI-H209; NCI-H524; NCI-H1048; NCI-H1930; DMS 79; NCI-H2081; NCI-H1092; NCI-H146; DMS 153; NCI-H2029; NCI-H1417; NCI-H510A; NCI-H526 (SCLC-total 19)NCI-H1568; NCI-H1155; NCI-H2122; NCI-H522; NCI-H1975; NCI-H838; NCI-H358; NCI-H1299; PC-9; NCI-H2228;NCI-H1770;NCI-H2030;NCI-H1993;NCI-H1703; NCI-H647; HCC15; NCI-H1693; NCI-H2106; COR-L105; A549; NCI-H460;NCI-H292 ; NCI-H2009; Calu-3; Calu-6; NCI-H441; NCI-H727; HCC827; NCI-H661; ChaGo-K-1; NCI-H1650; NCI-H596;NCI-H1395;A-427; EBC-1; GCT;NCI-H226; NCI-H1373; RERF-LC-AI; SW 1573; HCC4006, LXF-289; HARA; SK-MES-1; LK2; ABC-1 (NSCLC total 46) |
| Lymphoma | 22 | NAMALWA; Daudi; Raji; Mino; DB; Toledo; SU-DHL-6; MC116; OCI-Ly19;
WSU-DLCL2; Z-138; REC-1; Granta-519; RPMI 6666; Pfeiffer(x); Maver-1; Farage; SUDHL-5(x); JeKo-1; DoHH2; JVM-2; BJAB |
| Medullary Thyroid | 1 | TT |
| Medulloblastoma | 1 | Daoy |
| Melanoma | 5 | A375; A2058; C32; IGR-1;WN266-4 |
| Mesothelioma | 4 | TO211H; NCI-H28; NCI-H226; ACC-MESO-1(x) |
| Myeloma | 8 | RPMI 8226; MM.1S; NCI-H929; U266B1; OPM-2; LP-1; HuNS1; MM.1R |
| Nasopharyngeal | 1 | CNE |
| Neuroblastoma | 5 | BE(2)-C; SH-SY5Y; SK-N-DZ; CHP-212; KELLY |
| Osteosarcoma | 3 | 143B; SJSA-1; SK-ES-1 |
| Ovarian Cancer | 10 | OVCAR-3; A2780; A2780 (nude Rat); Caov-3; SKOV-3; OVIES; TOV21G; OVK18; COV434; TOV112D |
| Pancreatic Cancer | 10 | MIA PaCa-2; Capan-1; PANC-1; AsPC-1; CFPAC-1; BxPC-3; KP4; Panc.08.13; HPAF-II; Panc.03.27 |
| Prostate Cancer | 5 | PC-3; LNCaP(x1,x2); DU145; 22RV1; MDA-PCA-2B(+M) |
| Rhabdomyosarcoma | 2 | G-401; SJRH30 |
